Stanford researchers have designed a trainable portable device that can rapidly quantify liver steatosis (fat) prior to transplantation without a pathologist. Currently, rapid assessments are hindered by waiting for an available pathologist to provide results.
Stanford researchers have developed a crowdsourced framework for real-time robotic teleoperation with six degrees of freedom. Through smartphone controllers, RoboTurk enables large human workforces to remotely operate the robots without the need for prior training.
Stanford researchers have developed a method to make thin films of metallic glass with high strength, elastic limit, and corrosion resistance. These films are composed of metallic glass nanoparticles with high ductility.
Researchers at Stanford have developed, for the first time, a high-throughput method to systematically detect and identify silencer elements in the human genome.
These dual-function nanoparticles improve selectivity of myeloid treatment via identification and reduction of tumor progression in a two-step process: initial accumulation in tumor microenvironments, followed by targeted delivery of a therapeutic payload.
Stanford researchers have developed a compact, low-cost complete sensor solution (sensor plus reader) which can interpret fully-passive sensors through a simple handheld external reader. The readout mechanism can take measurements independent of the readout distance (i.e.
Stanford researchers have developed one of the smallest, active translational enhancers that can be adapted to control gene regulation. The translation enhancer is a short RNA stem-loop structure isolated from a Hox gene.
Stanford researchers have found a solution to enhance mRNA translation and stability by harnessing SARS-CoV2 genomic sequences themselves. They discovered that the SARS-CoV2 5' untranslated region (5' UTR) can be repurposed for increased translation and stability of any mRNA.
Stanford researchers at the Bao Research Group have developed a second-generation stretchable multi-sensor tag technology for detecting physiological signals.
Heart rhythm disorders are difficult to treat with conventional drug therapy and intraoperative injury to the cardiac conduction system (CCS) complicates heart-related surgeries and is a major cause of morbidity and mortality.
Stanford researchers have discovered that ribonucleoside vanadyl complexes can be used as an additive in transcription reactions resulting in ~2-fold increased yield.